Michelle Werner
Director/Board Member chez OMEGA THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Michelle C.
Werner is currently the CEO-Partner at Flagship Pioneering, the Chief Executive Officer at Alltrna, and the Director at Omega Therapeutics, Inc. She previously worked as a Director at Channel One, Inc., the US Brand Lead for Reyataz at Bristol Myers Squibb Co. from 2014 to 2015, and as the VP & Head-Global Haematology Franchise at AstraZeneca PLC in 2020.
Ms. Werner received her undergraduate degree from the University of Pennsylvania in 1997 and her MBA from the London Business School in 2005.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OMEGA THERAPEUTICS, INC.
-.--% | 28/08/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Michelle Werner
| Sociétés | Poste | Début |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Director/Board Member | 28/08/2023 |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/04/2022 |
Alltrna
 Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius. | Chief Executive Officer | 01/04/2022 |
Anciens postes connus de Michelle Werner
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 02/07/2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 02/05/2015 |
Channel One, Inc.
 Channel One, Inc. Services to the Health IndustryHealth Services Channel One, Inc. functions as a non-profit organization that offers programs that help feed people in need and that reduce waste. It operates a food bank, a food shelf, and a green garden as well as organize a commodity supplemental food program. The company was founded in February 1980 and is headquartered in Rochester, MN. | Director/Board Member | - |
Formation de Michelle Werner
| University of Pennsylvania | Undergraduate Degree |
| London Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Channel One, Inc.
Channel One, Inc. Services to the Health IndustryHealth Services Channel One, Inc. functions as a non-profit organization that offers programs that help feed people in need and that reduce waste. It operates a food bank, a food shelf, and a green garden as well as organize a commodity supplemental food program. The company was founded in February 1980 and is headquartered in Rochester, MN. | Health Services |
Alltrna
Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius. | Health Technology |
